Skip to content

Clinical trials

Phase 2/3 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 2/3 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20033
20042
20052
20071
20082
20101
20116
20121
20142
20151
20162
20182
20191
20211
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting4
Terminated3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University4
Bernardino Clavo, MD, PhD2
M.D. Anderson Cancer Center2
Mashhad University of Medical Sciences2
National Center for Complementary and Integrative Health (NCCIH)2
University of Pittsburgh2
Baylor College of Medicine1
Boston Medical Center1
Cedars-Sinai Medical Center1
Chinese University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders41
Generalized Anxiety Disorder4
Panic Disorder4
Stress Disorders, Post-Traumatic4
Fatigue3
Pain3
Alcoholism2
Breast Neoplasms2
Hypesthesia2
Mood Disorders2

Trials

Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.